Dr Michele Sterling Researcher | Educator | Author

Physio+10 focuses on the journeys of trailblazing Physiotherapists and todays conversation is with Dr Michele Sterling, who as a clinician come researcher, has carved out an important niche in the musculoskeletal world of whiplash associated disorders (WAD).

In this conversation with Michele we;
* Learn about prognostic factors to consider for patients with WAD
* See how the management of WAD has become more sophisticated over the last 20 years
* Hear about the challenges associated with research in the current political and economic environment
* Confirm the prime role Physiotherapy has in managing musculoskeletal injuries.

Biography
Michele Sterling is Professor in the Recover Injury Research Centre, Program Lead of the Designing Better Therapies research program and Director of the NHMRC Centre of Research Excellence (CRE) in Road Traffic Injury Recovery. She is a Musculoskeletal Physiotherapist and a Fellow of the Australian College of Physiotherapists. She is internationally recognised for her research on whiplash-associated disorders. Michele’s research focusses on the mechanisms underlying the development of chronic pain after injury, predictive algorithms for outcomes and developing effective interventions for musculoskeletal injury and pain. She has received over $13M in research funding from the NHMRC, ARC and industry partners. Michele has editorial roles with several leading journals and textbooks, and is a widely published author. She has received numerous awards for her research including the University of Queensland Foundation Research Excellence Award in 2005. Michele is an elected member of the leadership Council of the International Association for the Study of Pain (IASP).

Resources
Whiplash associated resources including WhipPredict
International Association for the Study of Pain

AAP Education
Educating aspiring health professionals

Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.